SCHEMBL3246534

SCHEMBL3246534

NNc1nnccc1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10817008 0.74 GOT1 (0.41) —
SCHEMBL1894224 0.73 — —
Hydrochloric Acid SCHEMBL11820325 0.73 GOT1 (0.41) —
SCHEMBL3946158 0.73 — —
SCHEMBL28013036 0.73 — —
SCHEMBL11823547 0.70 LMNA (0.43) —
SCHEMBL11826081 0.70 GOT1 (0.38) —
SCHEMBL15789458 0.68 GOT1 (0.36) —
Hydrochloric Acid SCHEMBL11824418 0.68 GOT1 (0.38) —
SCHEMBL29661956 0.68 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101981035-B Salts of triazoles as PAR1 inhibitors, their preparation and their use as medicaments SANOFI AVENTIS 2013-08-28 — — CN disclosed
US-8188083-B2 Triazolopyridazines ABBOTT LABORATORIES (US) 2012-05-29 — — US disclosed
EP-2170337-A1 NOVEL TRIAZOLOPYRIDAZINES Abbott Laboratories (US) 2010-04-07 — — EP disclosed
US-20090270402-A1 Novel triazolopyridazines ABBVIE INC. 2009-10-29 — — US disclosed
WO-2009005675-A1 NOVEL TRIAZOLOPYRIDAZINES ABBOTT LABORATORIES (US) 2009-01-08 — — WO disclosed
Send feedback